The Department of Obstetrics & Gynecology currently has five gynecological oncologists: Dr. Valerie Capstick, Dr. Jeanelle Sabourin, Dr. Alexandra Schepansky, Dr. Helen Steed, and Dr. Tiffany Wells.
Research in this division includes participation in clinical trials sponsored by the National Cancer Institute of Canada Clinical Trials Group (NCIC CTG), the Princess Margaret Hospital (PMH) Consortium and various pharmaceutical companies. Current clinical trials focus on new drug treatments for ovarian and endometrial cancer as well as surgical management of early cervical cancer.
The Gynecological Oncology division also collaborates with basic science researchers in the Department of Oncology. This includes translational studies investigating new targets for the early detection and treatment of ovarian cancer as well as molecular mechanisms underlying ovarian tumorigenesis.
Gynecological Oncology Research